Clinical Trial Update: Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of gemtuzumab ozogamicin and cyclosporine in older patients with relapsed acute myeloid leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED